Neurovance, Inc. Company Profile

00:33 EDT 2nd August 2014 | BioPortfolio

Neurovance has been spun out of Euthymics Bioscience, Inc. to advance EB-1020, a norepinephrine and dopamine-preferring reuptake inhibitor for ADHD. In addition to EB-1020, Neurovance also holds a substantial portfolio of research stage reuptake inhibitors.


News Articles [8 Associated News Articles listed on BioPortfolio]

Neurovance’s Non-Stimulant ADHD Drug Could Challenge Stimulants

Neurovance Inc. announced complete results from its Phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactiv

Neurovance Reports Positive Phase 2 Results For Non-Stimulant ADHD Drug

Neuroscience-focused clinical stage company Neurovance reported positive results from the Phase IIA pilot study of its non-stimulant drug for ADHD, EB-1020 SR, in adult male patients with all ADHD sub...

Neurovance closes $6.3M extension to its series A1 financing round to advance the development of EB-1020 SR

Neurovance, Inc. today announced that it has closed a $6.3 million extension to its series A1 financing round to further advance development of EB-1020 SR, a non-stimulant, for the treatment of all su...

Neurovance Closes $6.3M Financing to Support Further Development of EB-1020 SR in Adult ADHD

—Initiating Additional Study to Confirm Anticipated Reduced Abuse Potential— —EB-1020 SR Is a Non-Stimulant but with the Potential Efficacy Profile of a Stim...

Neurovance reports positive results from EB-1020 SR phase 2a pilot study in adult ADHD patients

Neurovance, Inc. today announced complete results from its phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactivity disord...

Neurovance financial update

Mass. developer of ADHD drug gets $6.3M funding boost

Neurovance, a Cambridge, Mass.-based biotech company developing a treatment for attention deficit hyperactivity disorder, sec -More- 

Neurovance’s EB-1020 SR for Adult ADHD Shows Stimulant-Like Efficacy and Good Tolerability in Phase 2a Trial

—Data Presented at Society of Biological Psychiatry 69th Annual Scientific Meeting— —Lays the Groundwork for EB-1020 SR as a Potential New Treatment Option f...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Neurovance Inc.

Neurovance is a neuroscience-focused, clinical-stage biopharmaceutical company that specializes in triple reuptake inhibitors specifically optimized for adult attention deficit hy...

Neurovance, Inc.

Neurovance has been spun out of Euthymics Bioscience, Inc. to advance EB-1020, a norepinephrine and dopamine-preferring reuptake inhibitor for ADHD. In addition to EB-1020, Neurov...

More Information about "Neurovance, Inc." on BioPortfolio

We have published hundreds of Neurovance, Inc. news stories on BioPortfolio along with dozens of Neurovance, Inc. Clinical Trials and PubMed Articles about Neurovance, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neurovance, Inc. Companies in our database. You can also find out about relevant Neurovance, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topics

Top five promising drugs Phase II (November 2013)
Latest News Clinical Trials Research Drugs Reports Corporate
THE FIVE MOST PROMISING DRUGS ENTERING PHASE II TRIALS Drug Disease Company Sel-G1 Sickle cell anemia Selexys Pharmaceuticals NSI-566 Amyotrophic lateral sclerosis...

Pediatrics
Latest News Clinical Trials Research Drugs Reports Corporate
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record